Some pets are susceptible to chronic eye conditions due to other health concerns and require additional home care and protection to prevent eye damage and blindness.
The draft guidance recommends Lucentis (Ranibizumab), Novartis is used as a treatment for the eye condition and if the final guidance--expected to be published next month goes ahead, this treatment would become available on the NHS.